ITMI960239A0 - - Google Patents
Info
- Publication number
- ITMI960239A0 ITMI960239A0 ITMI960239A ITMI960239A ITMI960239A0 IT MI960239 A0 ITMI960239 A0 IT MI960239A0 IT MI960239 A ITMI960239 A IT MI960239A IT MI960239 A ITMI960239 A IT MI960239A IT MI960239 A0 ITMI960239 A0 IT MI960239A0
- Authority
- IT
- Italy
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT96MI000239A IT1282586B1 (it) | 1996-02-08 | 1996-02-08 | Composizioni farmaceutiche per il trattamento biologico delle infezioni dovute a ceppi di enterococcus faecium resistenti agli |
| PCT/EP1997/000558 WO1997028812A2 (en) | 1996-02-08 | 1997-02-05 | Pharmaceutical compositions for biological treatment of infections by enterococcus faecium strains resistant to antibiotics and to vancomycin in particular (vre) |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT96MI000239A IT1282586B1 (it) | 1996-02-08 | 1996-02-08 | Composizioni farmaceutiche per il trattamento biologico delle infezioni dovute a ceppi di enterococcus faecium resistenti agli |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| ITMI960239A0 true ITMI960239A0 (en:Method) | 1996-02-08 |
| ITMI960239A1 ITMI960239A1 (it) | 1997-08-08 |
| IT1282586B1 IT1282586B1 (it) | 1998-03-31 |
Family
ID=11373201
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT96MI000239A IT1282586B1 (it) | 1996-02-08 | 1996-02-08 | Composizioni farmaceutiche per il trattamento biologico delle infezioni dovute a ceppi di enterococcus faecium resistenti agli |
Country Status (2)
| Country | Link |
|---|---|
| IT (1) | IT1282586B1 (en:Method) |
| WO (1) | WO1997028812A2 (en:Method) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU734715B2 (en) | 1996-02-26 | 2001-06-21 | California Institute Of Technology | Improved polyamides for binding in the minor groove of double stranded DNA |
| US5998140A (en) | 1996-07-31 | 1999-12-07 | The Scripps Research Institute | Complex formation between dsDNA and oligomer of cyclic heterocycles |
| US6518242B1 (en) | 1998-02-20 | 2003-02-11 | Theravance, Inc. | Derivatives of glycopeptide antibacterial agents |
| HK1040721B (en) | 1998-12-23 | 2003-10-17 | Cumberland Pharmaceuticals Inc. | Glycopeptide derivatives and pharmaceutical compositions containing the same |
| CN1550545A (zh) * | 2003-05-15 | 2004-12-01 | 肠球菌属乳酸菌以及乳酸菌死菌体的制造方法 | |
| JP2007522075A (ja) * | 2003-08-26 | 2007-08-09 | オブシェストボ エス オグラニチェンノイ オトベツトベンノスチュ“アレフ−ファルマ” | 肝不全の治癒並びに肝臓代謝の再生及び強化のためのエンテロコッカス・フェシウム（ＥｎｔｅｒｏｃｏｃｃｕｓＦａｅｃｉｕｍ）菌株の使用 |
| AU2005308160A1 (en) | 2004-11-29 | 2006-06-01 | National University Corporation Nagoya University | Glycopeptide antibiotic monomer derivatives |
| US8652504B2 (en) | 2005-09-22 | 2014-02-18 | Medivas, Llc | Solid polymer delivery compositions and methods for use thereof |
| JP5192384B2 (ja) | 2005-09-22 | 2013-05-08 | メディバス エルエルシー | ビス−（α−アミノ）−ジオール−ジエステル含有ポリ（エステルアミド）およびポリ（エステルウレタン）組成物および使用の方法 |
| US20070280964A1 (en) * | 2005-10-06 | 2007-12-06 | Ruth Knorr | Compositions and methods useful for modulating immunity, enhancing vaccine efficacy, decreasing morbidity associated with chronic FHV-1 infections, and preventing or treating conjunctivitis |
| ITMI20060860A1 (it) * | 2006-05-02 | 2007-11-03 | Truffini & Regge Farmaceutici Srl | Composizioni per lasalute di denti e gengive contenenti microrganismi eubiotici deidratati rivivificabili |
| WO2009081958A1 (ja) | 2007-12-26 | 2009-07-02 | Shionogi & Co., Ltd. | グリコペプチド抗生物質配糖化誘導体 |
| US8841440B2 (en) | 2008-04-01 | 2014-09-23 | Cornell University | Organo-soluble chitosan salts and chitosan-derived biomaterials prepared thereof |
| IT202200013138A1 (it) * | 2022-06-22 | 2023-12-22 | Cerbios Pharma Sa | Probiotico per l’uso nel trattamento di alterazioni infiammatorie della mucosa intestinale, in particolare obesità |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1112479B (it) * | 1979-04-02 | 1986-01-13 | Giuliani Sa | Composizione farmaceutica particolarmente atta alla terapia di enteriti e di affezioni diarroiche generiche |
| EP0405569A1 (de) * | 1989-06-30 | 1991-01-02 | Cernitin S.A. | Produkt mit antimikrobieller Wirksamkeit, Verfahren zu dessen Isolierung aus dem Kulturmedium von Streptokokkus faecium und pharmazeutisches Präparat, enthaltend dieses Produkt mit antimikrobieller Wirksamkeit |
-
1996
- 1996-02-08 IT IT96MI000239A patent/IT1282586B1/it active IP Right Grant
-
1997
- 1997-02-05 WO PCT/EP1997/000558 patent/WO1997028812A2/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| IT1282586B1 (it) | 1998-03-31 |
| WO1997028812A3 (en) | 1997-10-02 |
| WO1997028812A2 (en) | 1997-08-14 |
| ITMI960239A1 (it) | 1997-08-08 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 0001 | Granted |